In conclusion, this study clearly demonstrated that PDSS2, the first key enzyme for CoQ10 biosynthesis, is a novel downstream transcriptional target of SKA2 in lung cancer cells, and SKA2 represses PDSS2 transcription through the Sp1-binding sites in PDSS2 core promoter. Here, SP1 is linked to lung carcinoma.